Campath and Heparin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campath (alemtuzumab) and Heparin (heparin sodium). Common drug interactions include nephropathy toxic among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Campath and Heparin. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.

On Jul, 15, 2026

45 people who take Campath and Heparin together, and have interactions are studied.

What are the common drug interactions of Campath and Heparin, by gender? *:

female:

Nephropathy toxic (damage to kidney due to toxins)
Pneumonia legionella (pneumonia caused by the bacteria legionella)
Renal failure (kidney dysfunction)
Transplant rejection (a transplant material is not worked)
Acinetobacter bacteraemia (infection of bacteria)
Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
Alanine aminotransferase increased
Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Aspartate aminotransferase increased
Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)

male:

Renal failure acute (rapid kidney dysfunction)
Hypotension (abnormally low blood pressure)
Renal tubular necrosis (death of kidney tubules)
Sepsis syndrome (a clinical condition of blood infection)
Syncope (loss of consciousness with an inability to maintain postural tone)
Hypoxia (low oxygen in tissues)
Multi-organ failure (multisystem organ failure)
Respiratory failure (inadequate gas exchange by the respiratory system)
Hyperkalaemia (damage to or disease of the kidney)
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)

What are the common drug interactions of Campath and Heparin, by age (0-1 to 60+)? *:

0-1:

Acinetobacter bacteraemia (infection of bacteria)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Adenovirus infection
Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)
Enterobacter bacteraemia (enterobacter cloacae are nosocomial pathogens that can cause a range of infections such as bacteraemia, lower respiratory tract infection, skin)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)

2-9:

n/a

10-19:

Arteriovenous fistula occlusion
Diarrhoea
Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli)
Gastroenteritis (inflammation of stomach and intestine)
Hypotension (abnormally low blood pressure)
Renal failure (kidney dysfunction)
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
Graft loss (graft failure)
Thrombosis (formation of a blood clot inside a blood vessel)
Adenovirus infection

20-29:

Respiratory failure (inadequate gas exchange by the respiratory system)

30-39:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Herpes zoster
Hypertriglyceridaemia (excess of triglycerides in the blood)
Intestinal ulcer
Nephropathy toxic (damage to kidney due to toxins)
Pneumonia legionella (pneumonia caused by the bacteria legionella)
Renal failure (kidney dysfunction)
Transplant rejection (a transplant material is not worked)

40-49:

Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Aplasia (defective development or congenital absence of an organ or tissue)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood uric acid increased
Cytomegalovirus infection
Haemorrhage subcutaneous (bleeding from skin)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Multi-organ failure (multisystem organ failure)

50-59:

Delayed engraftment
Endocarditis (inflammation in heart muscle)
Enterococcal infection
Febrile neutropenia (fever with reduced white blood cells)
Fibrin d dimer increased
Graft loss (graft failure)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Laboratory test abnormal

60+:

Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Renal failure acute (rapid kidney dysfunction)
Neutropenia (an abnormally low number of neutrophils)
Platelet count decreased
Vomiting
White blood cell count decreased
Blood glucose increased
Blood potassium decreased
Blood pressure orthostatic
Blood sodium decreased

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 9 people, 20.00%
Diabetes: 7 people, 15.56%
Pain: 6 people, 13.33%
Immunodeficiency Disorders: 6 people, 13.33%
High Blood Pressure: 6 people, 13.33%
Constipation: 6 people, 13.33%
Stress And Anxiety: 5 people, 11.11%
Leukopenia (less number of white blood cells in blood): 5 people, 11.11%
Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 11.11%
Anaemia (lack of blood): 5 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and Heparin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously